A Phase 1 Safety, Tolerability, and Pharmacokinetics Study of AMG 794 With Claudin 6-positive Non-small Cell Lung Cancer, Epithelial Ovarian Cancer, and Other Malignant Solid Tumor Indications

Clinical trial NCT05317078 · TERMINATED

Trial details

NCT number: NCT05317078
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-squamous Non-small Cell Lung Cancer Epithelial Ovarian Cancer Claudin 6-positive Advanced/Metastatic Malignant Solid Tumors

Start date: 2023-02-28
Primary completion: 2023-12-19
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.